Publicaciones en colaboración con investigadores/as de Universidad Nacional de Costa Rica (32)

2023

  1. A review of three decades of use of the cattle brucellosis rough vaccine Brucella abortus RB51: myths and facts

    BMC Veterinary Research, Vol. 19, Núm. 1

  2. Brucellosis and One Health: Inherited and Future Challenges

    Microorganisms, Vol. 11, Núm. 8

  3. If You're Not Confused, You're Not Paying Attention: Ochrobactrum Is Not Brucella

    Journal of clinical microbiology, Vol. 61, Núm. 8, pp. e0043823

2022

  1. Efficacy of Brucella abortus S19 and RB51 vaccine strains: A systematic review and meta-analysis

    Transboundary and Emerging Diseases

  2. Facing the Human and Animal Brucellosis Conundrums: The Forgotten Lessons

    Microorganisms, Vol. 10, Núm. 5

  3. Pathogenicity and Its Implications in Taxonomy: The Brucella and Ochrobactrum Case

    Pathogens, Vol. 11, Núm. 3

2021

  1. Brucellosis

    Veterinary Vaccines: Principles and Applications (wiley), pp. 295-316

2019

  1. Corrigendum: Genetic and Phenotypic Characterization of the Etiological Agent of Canine Orchiepididymitis Smooth Brucella sp. BCCN84.3 (Frontiers in Veterinary Science, (2019), 6, 10.3389/fvets.2019.00175)

    Frontiers in Veterinary Science

  2. Genetic and phenotypic characterization of the etiological agent of canine orchiepididymitis smooth Brucella sp. BCCN84.3

    Frontiers in Veterinary Science, Vol. 6, Núm. JUN

2012

  1. Brucella β 1,2 Cyclic Glucan Is an Activator of Human and Mouse Dendritic Cells

    PLoS Pathogens, Vol. 8, Núm. 11

  2. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition

    PLoS Pathogens, Vol. 8, Núm. 5

2011

  1. Brucella abortus ornithine lipids are dispensable outer membrane components devoid of a marked pathogen- associated molecular pattern

    PLoS ONE, Vol. 6, Núm. 1

2010

  1. Proteomics-based confirmation of protein expression and correction of annotation errors in the Brucella abortus genome

    BMC Genomics, Vol. 11, Núm. 1

2009

  1. The differential interaction of Brucella and Ochrobactrum with innate immunity reveals traits related to the evolution of stealthy pathogens

    PLoS ONE, Vol. 4, Núm. 6

2007

  1. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection

    PLoS ONE, Vol. 2, Núm. 7

  2. BvrR/BvrS-controlled outer membrane proteins Omp3a and Omp3b are not essential for Brucella abortus virulence

    Infection and Immunity, Vol. 75, Núm. 10, pp. 4867-4874

  3. Extensive cell envelope modulation is associated with virulence in Brucella abortus

    Journal of Proteome Research, Vol. 6, Núm. 4, pp. 1519-1529

2006

  1. Characterization of Brucella abortus lipopolysaccharide macrodomains as mega rafts

    Cellular Microbiology, Vol. 8, Núm. 2, pp. 197-206

2005

  1. Brucella lipopolysaccharide acts as a virulence factor

    Current Opinion in Microbiology, Vol. 8, Núm. 1, pp. 60-66

  2. Cyclic β-1,2-glucan is a brucella virulence factor required for intracellular survival

    Nature Immunology, Vol. 6, Núm. 6, pp. 618-625